1. Home
  2. VANI vs FCNCP Comparison

VANI vs FCNCP Comparison

Compare VANI & FCNCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

N/A

Current Price

$1.23

Market Cap

119.0M

Sector

Health Care

ML Signal

N/A

Logo First Citizens BancShares Inc.

FCNCP

First Citizens BancShares Inc.

N/A

Current Price

$18.12

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VANI
FCNCP
Founded
1998
N/A
Country
United States
United States
Employees
N/A
18141
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
N/A
IPO Year
2014
1995

Fundamental Metrics

Financial Performance
Metric
VANI
FCNCP
Price
$1.23
$18.12
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $3.83
N/A
AVG Volume (30 Days)
★ 180.5K
11.1K
Earning Date
11-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 97.95
Revenue
$4,000,000.00
★ $9,541,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$0.19
Revenue Growth
N/A
★ N/A
52 Week Low
$0.92
$18.35
52 Week High
$1.92
$22.60

Technical Indicators

Market Signals
Indicator
VANI
FCNCP
Relative Strength Index (RSI) 44.74 13.59
Support Level $1.24 N/A
Resistance Level $1.25 $21.39
Average True Range (ATR) 0.04 0.29
MACD 0.00 -0.11
Stochastic Oscillator 53.00 1.06

Price Performance

Historical Comparison
VANI
FCNCP

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

About FCNCP First Citizens BancShares Inc.

First Citizens is a US regional bank with total assets of around $237 billion as of June 30, 2026. Headquartered in Raleigh, North Carolina, First Citizens' largest markets are North Carolina, South Carolina, and California. The bank has a track record of acquiring troubled banks from the FDIC, such as Silicon Valley Bridge Bank in 2023, which doubled its asset base. First Citizens offers products and services across retail, commercial, wealth management, and railcar leasing. In 2025, First Citizens derived over 95% of its earnings from banking and less than 5% from railcar leasing.

Share on Social Networks: